Today’s AI Top Pick: AZN

7/16/2026 · AI Conviction screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · AI ConvictionAZNBUY NOW8.4 / 107/16/2026

AstraZeneca is the cleanest multi-timeframe setup in this pool combined with a genuine 'not-chasing' entry. The 1h, 4h, and 1d forecasts are ALL positive across short/mid/long horizons: 1h +9.37/+7.92/+10.74%, 4h +8.59/+10.14/+11.14%, 1d +1.75/+4.12/+2.46%. That's three timeframes in unanimous agreement, and Kronos bullish_prob prints 1.0 with near_term_bullish 0.6 — the model is voting with the analyst thesis (fundamental_score 7, recom 1.63, targetUpsidePct 28.9%). Critically, this is a dip buy rather than a chase. AZN sits at just 13.8% of its 21-bar daily range and 0% of its weekly range, with drawdowns of -13.54% (daily) and -19.05% (weekly). RSI is 38.22 — oversold territory. Compare that to CME (97.95% of 4h range), MELI (99.69% weekly), or BLK (100% daily/weekly): those setups require chasing a top. AZN offers you the same forecast-model conviction but with skin already off the price. The fundamentals are supportive: fwdPe 14.54, PEG 1.2, profitMargin 17.19%, ROE 23.51%, salesYoY +9.93%, gross margin 74.32%, debtEq 0.72. Short float is a rounding-error 0.10%. And the recent newsflow is actively positive — the July 15 in-licensing of Zegfrovy from Dizal (headlined as a $1.5B lung cancer deal) and the 'oncology engine keeps running' Seeking Alpha piece are real catalysts, not narrative. The one honest negative is the weekly forecast (-13% to -21%), but that likely reflects the trailing tape rather than forward-looking earnings — and with price already at 0% of the weekly range, most of that has arguably happened. Why today vs. waiting: near-term forecasts are asymmetric to the upside from an oversold base; waiting risks missing the mean-reversion pop the 1h/4h models are calling for (short-horizon +8-9%). Combine bullish_prob 1.0, oversold RSI, low position-in-range, and a fresh positive catalyst — this is the buy.

Entry zone

$167.50 – $170.00 (current $168.73, scale in on any dip to the low-$167s)

Stop loss

$159.50 (below the 4h/1d drawdown low near -13.5%, ~5.5% risk)

First target

$182 (roughly the 4h/1d forecast mid-horizon +8-10% zone)

Longer target

$195 – $210 (aligns with 1h long-horizon +10.7% and moves toward analyst target upside of +28.9% / ~$217)

Risks

Weekly forecasts print -13.24% short / -15.91% mid / -20.70% long — if the daily/4h bounce fails, the weekly downtrend regime dominates
Price is at 0% of its 21-bar weekly range with a -19.05% weekly drawdown — you are catching a falling knife on the higher timeframe
Perf YTD -4.06% and healthcare sector rotation risk; Wainua setback headline is already public but sentiment remains fragile
FX and UK/EU regulatory exposure on the ADR; recom 1.63 is good but not stellar (vs. NVDA/TSM at 1.26-1.27)
Forecast optimism is concentrated on the short-mid horizon — if 1h/4h models are wrong, there's no weekly support catching the trade

Honorable mentions

CMEFull-house bullish_prob 1.0 AND near_term_bullish 1.0, with every short-timeframe forecast strongly positive (1d +4.33/+10.49/+12.47%, 4h +7.38/+6.10/+14.67%). Downside is it's at 97.95% of the 4h range so you're paying near the intraday high, and weekly forecasts are negative. Great earnings-run setup (release next week) but pay the pullback.

FOXbullish_prob 1.0 and near_term_bullish 1.0 with 1h/4h/1d all positive (1d +4.12/+13.29/+11.11%). Cheapest fwdPe in the group (8.66) and targetUpsidePct 41.1%. Held back by weekly forecast -30.08% long and 97.24% of daily range — a small pullback would make it a top pick.

Full ranking (29)

#	Symbol	Verdict	Score	Read
1	AZN	BUY NOW	8.4	1h/4h/1d forecasts all positive, RSI 38 oversold, 13.8% of daily range — best conviction-plus-entry combo in the pool.
2	CME	BUY PULLBACK	7.6	Perfect bullish_prob/near_term (1.0/1.0) and strong forecasts on every short TF, but 97.95% of 4h range means chase risk.
3	FOX	BUY PULLBACK	7.4	1.0/1.0 probability with 1d fc +13.29% mid and cheapest fwdPe in the group, but at 97% of daily range.
4	CDW	BUY PULLBACK	7.0	Weekly forecast +36.09% long and bullish_prob 1.0, sitting -9.27% below highs — attractive but 1d only mildly positive.
5	AWK	BUY PULLBACK	6.2	bullish_prob 0.8 with 1d forecasts all positive (+3.74% long), low position in range, but forecast magnitudes are small.
6	MELI	WAIT	5.8	bullish_prob 1.0 and 1d fc +10.23% mid, but 99.69% of weekly range — pure chase from here.
7	MDLN	WAIT	5.5	Only 1h data (fc +9.32% long) — insufficient multi-TF confirmation to size up.
8	GEN	WAIT	5.2	near_term_bullish 0.8 but all forecasts negative on longer horizons; RSI 60 and at 99% of weekly range.
9	FIVE	WAIT	5.0	1h positive but 4h/1d/1wk turn mixed to negative; bullish_prob only 0.2.
10	CLS	WAIT	4.8	1h fc long +20.78% is eye-catching but 1d/1wk forecasts are catastrophic (-26% and -71%).
11	DXCM	WAIT	4.5	Weekly forecast long +11.39% is nice but 4h and 1d forecasts negative; bullish_prob 0.
12	HUBB	WAIT	4.2	1h fc long +6.24% but weekly forecasts collapse (-28.36%); NSI acquisition digestion phase.
13	LECO	WAIT	4.0	1h/4h fc mildly positive but 1d/1wk turn deeply negative (-26% wk long).
14	BLK	AVOID	3.8	At 100% of both daily and weekly range with every forecast negative — textbook chase-then-fade.
15	TSM	AVOID	3.6	Great fundamentals but weekly forecast -68.94% long and daily -35.42% mid are damning; TSMC stock slid despite crushing Q2.
16	NVDA	AVOID	3.5	Weekly forecast -66.13% long and daily -15.60% mid override the analyst thesis; AI stocks weakening on TSMC read-through.
17	FCX	AVOID	3.4	1d fc -18.47% mid and 1wk -34.96% long; commodity pullback regime.
18	GRMN	AVOID	3.3	Weekly forecast -35.82% long overwhelms mildly positive 1h; PEG 1.83 offers no cushion.
19	CPAY	AVOID	3.2	At 100% of daily/weekly range with 1d fc -16.25% and 1wk -17.36% — top of range breakdown risk.
20	ECG	AVOID	3.0	1d fc -34.92% mid and -36.12% long; already up 61% YTD, mean-reversion setup.
21	DECK	AVOID	2.9	Every TF forecast negative; SeekingAlpha 'slowing growth' headline confirms tape.
22	GD	AVOID	2.8	Weekly fc -30.58% long, fundamental_score 1.5, and Trump singling them out to accelerate submarine production adds uncertainty.
23	BKH	AVOID	2.7	1wk forecasts -25 to -30%; short float 12.38% and only +2.58% recent.
24	EZPW	AVOID	2.5	1d fc -44.37% mid, 1wk -66.60% long; up 135% on the year with 21.45% short float — mean reversion setup.
25	FWONK	AVOID	2.4	Every forecast negative, at 100% of weekly range, PEG 4.45.
26	HSBC	AVOID	2.2	At 100% of 4h/1d/1wk range with weekly fc -61% long — pure top.
27	HAFN	AVOID	2.1	1d fc -19.65% mid, 1wk -19.14% long; epsNextY -36% erases the value case.
28	ARQT	AVOID	1.9	1h fc -19.84% mid despite positive FDA news; negative profitMargin and truncated data.
29	DOCN	AVOID	1.6	Just announced dilution ($500M convert repurchase via direct stock offering); 1d fc -69.94% mid confirms the tape.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord